PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04660773|
Recruitment Status : Recruiting
First Posted : December 9, 2020
Last Update Posted : December 9, 2020
Patients will be randomly assigned into 2 groups:
- Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months.
- Group B: (20 patients) will receive pregabalin oral therapy (50mg after each dialysis session) for 2 months.
|Condition or disease||Intervention/treatment||Phase|
|Refractory Uremic Pruritis||Device: NB UVB phototherapy Drug: Pregabalin||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||NARROW BAND UVB PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY PRURITIS IN END STAGE RENAL DISEASE PATIENTS|
|Estimated Study Start Date :||January 1, 2021|
|Estimated Primary Completion Date :||December 1, 2021|
|Estimated Study Completion Date :||December 1, 2021|
Active Comparator: NB UVB phototherapy
(20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months.
Device: NB UVB phototherapy
ultraviolet phototherapy sessions
Active Comparator: pregabalin
20 patients) will receive pregabalin oral therapy (50mg after each dialysis session) for 2 months.
- 5 D-itching scale [ Time Frame: two month ]assessment of degree, duration, direction, disability and distribution of itching
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04660773
|Contact: marwa firstname.lastname@example.org|
|Faculty of Medicine||Recruiting|
|Alexandria, Egypt, 21521|
|Contact: alexandria university faculty of medicine 034862506 email@example.com|